Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195806 · ClinicalTrials.gov registry record · Phase 3
Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 315
- Enrollment target
NCT00195806 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 315 participants.
The verdict
NCT00195806, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 315 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if long-term treatment, up to 1 year, with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents.
Interventions
- DRUG divalproex sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2005-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00195806
The ClinicalTrials.gov registry entry for NCT00195806 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which divalproex sodium is the first listed.
NCT00195806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00195806 about?
NCT00195806 is a clinical study titled "Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine". The purpose of this study is to determine if long-term treatment, up to 1 year, with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents.
What is the current status of trial NCT00195806?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 315 participants. The study started on 2005-02.
What interventions are being tested in trial NCT00195806?
The interventions under investigation include: divalproex sodium (DRUG).
Who is sponsoring clinical trial NCT00195806?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.